Annual Shareholders Equity
$275.41 M
-$77.08 M-21.87%
December 31, 2023
Summary
- As of February 7, 2025, RARE annual stockholders equity is $275.41 million, with the most recent change of -$77.08 million (-21.87%) on December 31, 2023.
- During the last 3 years, RARE annual shareholders equity has fallen by -$878.96 million (-76.14%).
- RARE annual shareholders equity is now -76.14% below its all-time high of $1.15 billion, reached on December 31, 2020.
Performance
RARE Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$346.83 M
-$85.59 M-19.79%
September 30, 2024
Summary
- As of February 7, 2025, RARE quarterly stockholders equity is $346.83 million, with the most recent change of -$85.59 million (-19.79%) on September 30, 2024.
- Over the past year, RARE quarterly shareholders equity has increased by +$315.11 million (+993.61%).
- RARE quarterly shareholders equity is now -69.96% below its all-time high of $1.15 billion, reached on December 31, 2020.
Performance
RARE Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
RARE Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.9% | +993.6% |
| 3 y3 years | -76.1% | -62.9% |
| 5 y5 years | -54.8% | -52.3% |
RARE Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -70.2% | at low | -62.4% | +993.6% |
| 5 y | 5-year | -76.1% | at low | -70.0% | +993.6% |
| alltime | all time | -76.1% | +2487.8% | -70.0% | +993.6% |
Ultragenyx Pharmaceutical Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $346.83 M(-19.8%) |
| Jun 2024 | - | $432.42 M(+208.3%) |
| Mar 2024 | - | $140.26 M(-49.1%) |
| Dec 2023 | $275.41 M(-21.9%) | $275.41 M(+768.4%) |
| Sep 2023 | - | $31.71 M(-75.4%) |
| Jun 2023 | - | $129.03 M(-41.5%) |
| Mar 2023 | - | $220.48 M(-37.5%) |
| Dec 2022 | $352.49 M(-61.8%) | $352.49 M(-24.8%) |
| Sep 2022 | - | $468.83 M(-30.9%) |
| Jun 2022 | - | $678.07 M(-14.9%) |
| Mar 2022 | - | $796.42 M(-13.7%) |
| Dec 2021 | $922.56 M(-20.1%) | $922.56 M(-1.2%) |
| Sep 2021 | - | $933.67 M(-4.0%) |
| Jun 2021 | - | $972.17 M(-7.8%) |
| Mar 2021 | - | $1.05 B(-8.6%) |
| Dec 2020 | $1.15 B(+76.6%) | $1.15 B(+73.3%) |
| Sep 2020 | - | $666.19 M(-4.2%) |
| Jun 2020 | - | $695.59 M(+14.2%) |
| Mar 2020 | - | $609.15 M(-6.8%) |
| Dec 2019 | $653.76 M(+7.4%) | $653.76 M(-10.1%) |
| Sep 2019 | - | $727.26 M(-11.3%) |
| Jun 2019 | - | $819.79 M(-7.5%) |
| Mar 2019 | - | $886.73 M(+45.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $608.91 M(+58.8%) | $608.91 M(-8.1%) |
| Sep 2018 | - | $662.60 M(-5.9%) |
| Jun 2018 | - | $703.97 M(-2.7%) |
| Mar 2018 | - | $723.66 M(+88.7%) |
| Dec 2017 | $383.45 M(-19.1%) | $383.45 M(+4.9%) |
| Sep 2017 | - | $365.56 M(-14.9%) |
| Jun 2017 | - | $429.45 M(-12.1%) |
| Mar 2017 | - | $488.48 M(+3.1%) |
| Dec 2016 | $473.97 M(-10.8%) | $473.97 M(+4.0%) |
| Sep 2016 | - | $455.89 M(+2.7%) |
| Jun 2016 | - | $443.89 M(-9.4%) |
| Mar 2016 | - | $489.82 M(-7.8%) |
| Dec 2015 | $531.09 M(+187.2%) | $531.09 M(-7.9%) |
| Sep 2015 | - | $576.76 M(+80.6%) |
| Jun 2015 | - | $319.28 M(-6.4%) |
| Mar 2015 | - | $341.12 M(+84.4%) |
| Dec 2014 | $184.94 M(+269.1%) | $184.94 M(-7.2%) |
| Sep 2014 | - | $199.33 M(+30.2%) |
| Jun 2014 | - | $153.08 M(-7.6%) |
| Mar 2014 | - | $165.71 M(+230.7%) |
| Dec 2013 | $50.11 M(-40.6%) | $50.11 M(-18.1%) |
| Sep 2013 | - | $61.15 M(-27.5%) |
| Dec 2012 | $84.34 M(+692.4%) | $84.34 M |
| Dec 2011 | $10.64 M | - |
FAQ
- What is Ultragenyx Pharmaceutical annual stockholders equity?
- What is the all time high annual shareholders equity for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical annual shareholders equity year-on-year change?
- What is Ultragenyx Pharmaceutical quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical quarterly shareholders equity year-on-year change?
What is Ultragenyx Pharmaceutical annual stockholders equity?
The current annual shareholders equity of RARE is $275.41 M
What is the all time high annual shareholders equity for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high annual stockholders equity is $1.15 B
What is Ultragenyx Pharmaceutical annual shareholders equity year-on-year change?
Over the past year, RARE annual stockholders equity has changed by -$77.08 M (-21.87%)
What is Ultragenyx Pharmaceutical quarterly stockholders equity?
The current quarterly shareholders equity of RARE is $346.83 M
What is the all time high quarterly shareholders equity for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high quarterly stockholders equity is $1.15 B
What is Ultragenyx Pharmaceutical quarterly shareholders equity year-on-year change?
Over the past year, RARE quarterly stockholders equity has changed by +$315.11 M (+993.61%)